Instead of worrying whether your peptides are still effective or wasting money discarding good peptides too early, you get personalized protocols with clear timelines, storage guidance, and expert AI support whenever questions arise
10.1002/pca.2428 124 TangY
Tirzepatide, a glucose-dependent insulinotropic peptide (GIP) and human glucagon-like peptide-1 (GLP-1) receptor agonist, was recently approved to treat type 2 diabetes
Therefore, the development of an oral delivery strategy for peptide GLP-1R agonists is expected to reduce these adverse effects and improve patient compliance and quality of life (Rosenstock et al., 2021)
DOI: 10.1111/ijfs.12749 69
Tumor Suppressors: In some cancer types, p53 suppresses GLS activity